Insulin glargine-aldy^↗

aldy[All Fields] AND insulin[All Fields]

• A scoped product-label account is available separately; it is not an independent literature review.
• Other aliases, parent molecules, study-family linkage and full-text appraisal remain separate work.
• Zero aldy-and-insulin name matches do not mean zero human evidence. The product label draws on reference insulin glargine studies; those parent studies must not be described as trials conducted specifically with the biosimilar.

Showing 0 of 0 record decisions, with included studies and unresolved records first. The versioned data inventory retains every record and study-family link.

products.active_ingredients.name:"INSULIN GLARGINE-ALDY"

• Zero results describe this query response only, not absence of FDA approval or worldwide nonapproval.
• This endpoint does not inventory every label, advisory proceeding, safety communication or regulatory document. Application inclusion does not establish current marketing or approval of every use.

Showing 1 of 1 record decisions, with included studies and unresolved records first. The versioned data inventory retains every record and study-family link.

1. FDA BLA761412 — include: Retrieved application lists a matching ingredient or its salt; document and product review remain separate. Listed ingredients: INSULIN GLARGINE-ALDY.

Case-insensitive word-boundary identity terms: ["Insulin glargine-aldy", "Langlara"]

• Document appraisal and national European sources remain open.
• Zero matches apply only to these feed fields and terms; orphan designation is not approval.

Showing 0 of 0 record decisions, with included studies and unresolved records first. The versioned data inventory retains every record and study-family link.

Case-insensitive word-boundary identity terms: ["Insulin glargine-aldy", "Langlara"]

• Document appraisal and national European sources remain open.
• Zero matches apply only to these feed fields and terms; orphan designation is not approval.

Showing 0 of 0 record decisions, with included studies and unresolved records first. The versioned data inventory retains every record and study-family link.

Case-insensitive word-boundary identity terms: ["Insulin glargine-aldy", "Langlara"]

• Document appraisal and national European sources remain open.
• Zero matches apply only to these feed fields and terms; orphan designation is not approval.

Showing 0 of 0 record decisions, with included studies and unresolved records first. The versioned data inventory retains every record and study-family link.

"Insulin glargine-aldy" OR "Langlara"

• Registration is not evidence that a study succeeded, that results were published, or that a use is approved.
• Other registries, unregistered studies and additional aliases remain outside this query.

Showing 0 of 0 record decisions, with included studies and unresolved records first. The versioned data inventory retains every record and study-family link.